MYWOT

Child safety

Very poor

Confidence

0%

Trustworthiness

Excellent

Confidence

51%

MALICIOUS CONTENT INDICATORS

Availability or unavailability of the flaggable/dangerous content on this website has not been fully explored by us, so you should rely on the following indicators with caution.

Boryung.co.kr most likely does not offer any malicious content.

  • Siteadvisor

    Safety status

    N/A

  • SAFEBROWSING

    Safety status

    Safe

  • Phishtank

    Safety status

    N/A

Secure connection support

HTTPS

Boryung.co.kr provides SSL-encrypted connection.

ADULT CONTENT INDICATORS

Availability or unavailability of the flaggable/dangerous content on this website has not been fully explored by us, so you should rely on the following indicators with caution.

Boryung.co.kr most likely does not offer any adult content.

Popular pages

  • BORYUNG

    BORYUNG

  • Boryung

    Copyright (C) 2022 by Boryung Pharmaceutical Co.,Ltd. All Rights Reserved.

  • Boryung

    30tabs Kanarb Plus [Fimasartan 60mg Hydrochlorothiazide (USP), Fimasartan 120mg Hydrochlorothiazide (USP) 12.50 mg 12.50 mg,] (Oral ...

  • BORYUNG

    BORYUNG 닫기 | 136, Changgyeonggung-ro, Jongno-gu, Seoul, Republic of Korea (03127) Copyright (C) 2022 by Boryung Co.,Ltd. All Rights Reserved. TOP

  • BORYUNG

    BORYUNG CEO(Pharma Biz)Daniel Chang I want to describe Boryung's 2022 as a year of the half-moon. One side of the company was visible and shining, whereas the other was unknown. Thanks to your support...

  • Boryung

    Pipeline Introduction After 12 years of research, Boryung succeeded in developing the first domestic hypertension drug, ‘Kanarb’. By independently carrying out all the necessary steps – candidate mate...

Open neighbouring websites list